Bringing the Mycobiome to the Forefront

The Mycobiome, which was named by our Co-Founder and CSO Dr. Ghannoum, is the fungal community living in and on an organism…

it’s also a part of your microbiome

EVERY MOLECULE MATTERS

Our research shows that bad fungi & bad bacteria work together to create biofilms that can impair gut health.

These biofilms can contribute to a whole host of unwanted symptoms in humans.

Dr. Ghannoum's unique research & findings of the interplay between the fungal matrix and the bacteriome shed a new light on what microbiome balance really is.

The fungal hyphae and the metabolites they produce create biofilms and can facilitate an inflamatory response, creating unwanted sysmptoms in patients.

OUR PATENTED & CLINICALLY PROVEN
SOLUTION TO REDUCE BLOATING

New data has shown that fungi has a great influence on both the healthy (i.e. balanced) and diseased (dysbiotic) states of the human gut.

BLOATBIOTIC™ takes that science and uses it to promote gut health and significantly reduce bloating.

BLOATBIOTIC™ targets specific enzymes within a user's gut that are the primary cause of bloating.

Patented Formulation to reduce bloating & gastrointestinal distress
Published clinical trial that demonstrates gut rebalancing and bloat reduction
Clinically tested biofilm buster & immune system modulator
Created by the Father of the Mycobiome, Dr. Mahmmoud Ghannoum, at Case Western Reserve University

BLOATBIOTIC™ BREAKS DOWN DIGESTIVE BIOFILMS

BIOHM FX™ has been clinically shown to break down digestive biofilms and reduce bloating, mild constipation, abdominal discomfort, flatulence and improve gut function ratings (GSRS)*

TWO SUCCESSFUL
CLINICAL TRIALS

SEVERAL SUCCESSFUL
IN VITRO STUDIES

FOUR PUBLISHED
PAPERS (OTHERS IN
MANUSCRIPT STAGE)

ONE ISSUED PATENT
(SEVERAL PENDING)

Showing breakdown of digestive biofilms through the use of BIOHM FX™. Before BIOHM FX™ left & after BIOHM FX™ right.

*In a recently conducted randomized, placebo-controlled study in 60 healthy adults over 6 weeks, BIOHM FX™ significantly improved self-reported ratings of gut function, mild bloating and abdominal discomfort compared to placebo (P<0.05). BIOHM FX™ also improved other measures of gut function within the treatment group after 6 weeks.

The Scientist Behind BIOHM FX™

A company born from the leading mycobiome researcher’s vision to advance microbiome health for everyone.

"Dr. Mahmoud Ghannoum, the scientist who is now known as the leading microbiome researcher in the world... "

Our Scientific Advisor Board

Our scientific team is supporting numerous clinical trials in both design, implementation and testing support.

Tara Scott MD, FACOG, ABAARM, ABOIM, CNMP

Medical Director, Revitalize Medical Group Forum Health Akron

Francoise Adan MD

Chief Whole Health and Well-Being Officer

Director UH Connor Whole Health
Christopher M. and Sara H. Connor Chair in Integrative Health
University Hospitals Health System
Assistant Professor of Psychiatry Case Western Reserve University
University Hospitals Distinguished Physician 2021
Board of Directors Immediate Past Chair of the Academic Consortium of Integrative Medicine and Health

Our Science-Driven Leadership Team

Our expertise in bacteria and fungi provides a robust platform to build scientific understanding that informs new product development.

Afif Ghannoum
CEO
Sam Schatz
President
Michael Haritakis
COO
Dr. Mahmoud Ghannoum
CSO
David Keller
Director, Science & Regulatory

Our Industry-leading Partners

BIOHM® Clinical is a trusted partner in research, technology, and product development.

APPLIED FOOD SCIENCES